Coenzyme Q10 Supplementation Modulates Hepatic Lipidomic Alterations and Attenuates Metabolic Dysfunction-Associated Steatohepatitis in Mice
Nutrients · 2026
DOI: 10.3390/nu18040588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Yula Go und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food & Nutrition, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Ubiquinone, Liver, Dietary Supplements, Lipidomics. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, BK21 FOUR program of Graduate School, Kyung Hee University, Korea Basic Science Institute.
Abstract (Originalsprache)
Background/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is a chronic liver disorder with limited effective therapeutic options. Emerging lipidomic studies suggest that alterations in membrane-associated lipids contribute to MASH pathophysiology; however, nutritional interventions capable of modifying these lipid alterations remain poorly defined. This study aimed to investigate the effects of coenzyme Q10 (CoQ) supplementation on hepatic lipidomic remodeling in a methionine- and choline-deficient (MCD) diet-induced mouse model of MASH.
Methods
Male C57BL/6J mice were fed a methionine- and choline-sufficient diet or an MCD diet for 4 weeks, with MCD-fed mice receiving vehicle or CoQ (100 mg/kg body weight/day). Hepatic lipid profiles were assessed using untargeted LC–MS-based lipidomics, and expression of genes involved in phospholipid and sphingolipid metabolism was quantified by quantitative real-time PCR.
Results
CoQ supplementation significantly attenuated liver injury induced by the MCD diet, as evidenced by reduced histological severity and decreased serum ALT and AST levels. Lipidomic analyses revealed marked alterations in hepatic phospholipid and sphingolipid profiles during MASH development. CoQ was associated with remodeling of phospholipid composition, increasing phosphatidylcholine (PC) species and reducing phosphatidylethanolamine (PE) species, resulting in an increased hepatic PC to PE ratio. This change was accompanied by upregulation of Pemt (phosphatidylethanolamine N-methyltransferase). In contrast, sphingolipid accumulation induced by the MCD diet remained largely unchanged by CoQ, and Smpd1 (sphingomyelin phosphodiesterase 1) expression was not altered.
Conclusions
CoQ supplementation was associated with attenuation of MCD diet-induced MASH and modulation of hepatic phospholipid homeostasis, supporting its potential as a nutritional intervention targeting membrane lipid dysregulation in MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food & Nutrition, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Chemistry, Gachon University, Seongnam 13120, Republic of Korea.
ORCID-Profile: Heeju Joung, Sang Yun Han
Förderung
- National Research Foundation of Korea
- BK21 FOUR program of Graduate School, Kyung Hee University
- Korea Basic Science Institute
Zitieren
APA
Go, Y., Joung, H., Han, S. Y., & Chung, J. (2026). Coenzyme Q10 Supplementation Modulates Hepatic Lipidomic Alterations and Attenuates Metabolic Dysfunction-Associated Steatohepatitis in Mice. Nutrients. https://doi.org/10.3390/nu18040588
Vancouver
Go Y, Joung H, Han SY, Chung J. Coenzyme Q10 Supplementation Modulates Hepatic Lipidomic Alterations and Attenuates Metabolic Dysfunction-Associated Steatohepatitis in Mice. Nutrients. 2026. doi:10.3390/nu18040588
BibTeX
@article{Go2026,
author = {Go, Yula and Joung, Heeju and Han, Sang Yun and Chung, Jayong},
title = {Coenzyme Q10 Supplementation Modulates Hepatic Lipidomic Alterations and Attenuates Metabolic Dysfunction-Associated Steatohepatitis in Mice},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18040588}
}
EUVIMED